By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry.
Glenmark Pharmaceuticals announced its financial results for the fourth quarter ended March 31, 2022
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Glofitamab has the potential to offer a readily available, fixed-duration CD20xCD3 bispecific antibody treatment approach for people with aggressive lymphoma
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Pemetrexed for Injection has a market size of USD 1,236 mn (as per IQVIA MAT March’22)
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
Subscribe To Our Newsletter & Stay Updated
